Pancreas Disease

9

Review clinical trials related to Pancreas Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A COMBINATION OF RECTAL INDOMETHACIN AND COLD WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS -RCT

Endoscopic retrograde cholangiopancreatography (ERCP) has emerged as the primary modality in the management of biliary and pancreatic disease. The complications occurring from ERCP can range from mild to fatal. Procedure related complications are Pancreatitis , Bleeding , Infections- Cholangitis, Cholecystitis , Perforations of which Post-ERCP pancreatitis (PEP) is the most common serious adverse event. Reported incidence of PEP is 8.6-10.7% according to studies(overall RCTs).In India it is 6.6% (2020 study). Prevention as well as early detection and management of PEP results in a satisfactory outcome. Multiple RCTs and meta-analyses show rectal indomethacin/diclofenac significantly reduce PEP in average- and high-risk patients; now recommended by ASGE/ESGE for nearly all ERCPs. Other measures for prevention of PEP are prophylactic pancreatic duct stents in high-risk anatomy/instrumentation; wire-guided cannulation; minimizing PD contrast; periprocedural aggressive lactated Ringer's hydration. Cryoprevention effect was shown to reduce postprocedure papillary edema and thus lower the risk of PEP 1. Rectal NSAIDs reduce but do not eliminate PEP. 2. Cold-water ampullary cooling is biologically plausible but under-studied. 3. First study to demonstrate if combination of rectal indomethacin and cold-water irrigation may have a synergistic effect. 4. First study in Indian population.

Participants needed: 150
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Asian Institute of Gastroenterology, IndiaUpdated: Jun 12, 2026Locations: 1
Eligibility criteria

Standard ERCP indication [+1]

Pregnancy and lactation [+10]

Status: Recruiting

Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries

Hepatobiliary and Pancreatic surgery is associated with substantial risk of postoperative complications. Albumin is a negative acute phase protein. Its rapid decline may be due to degree of inflammation due to surgical procedures. The decline may due to multifactorial causes. Currently, contemporary data regarding the time to recovery of albumin, as a marker for early recovery of patient from surgical stress is sparse. Delta albumin is influenced by perioperative fluid administration and albumin supplementation. Delta albumin may not reflect the true surgical stress. Early post op albumin is a reflection of intraoperative events and not postoperative recovery or events and is unpredictable. Shorter recovery time of albumin is associated with less post op complications and hospital stay. Earlier recovery of albumin predicts lower morbidity and shorter hospital stay.

Participants needed: 1,000
Trial details
Age: 13-80Biological sex: AllType: ObservationalSponsor: Institute of Liver and Biliary Sciences, IndiaUpdated: Dec 31, 2025Locations: 1
Eligibility criteria

All patients undergoing major Hepato pancreatico Biliary surgeries. [+2]

Patients who refuse or are unable to give consent. [+3]

Status: Recruiting

Artificial Intelligence in Endoscopic Ultrasound

The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.

Participants needed: 310
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Orlando Health, Inc.Updated: May 31, 2025Locations: 1
Eligibility criteria

Age ≥ 18 years [+1]

Age < 18 years

Status: Not yet recruiting

Intermittent Fasting for Pancreatitis

The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.

Participants needed: 64
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: H. Lee Moffitt Cancer Center and Research InstituteUpdated: Apr 22, 2025Locations: 1
Eligibility criteria

Age ≥ 18 year [+2]

Age < 18 years [+11]

Status: Recruiting

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Stanford UniversityUpdated: Apr 1, 2025Locations: 1
Eligibility criteria

Older than 18 with pancreas cyst [+1]

Unable to provide consent [+1]

Status: Recruiting

Radiology Registry on Pancreatic Malignancies

The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.

Participants needed: 1,300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: IRCCS San RaffaeleUpdated: Apr 12, 2024Locations: 1
Eligibility criteria

≥18 years of age [+2]

Patients with non-primary pancreatic disease

Status: Recruiting

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Umeå UniversityUpdated: Nov 30, 2022Locations: 1
Eligibility criteria

Confirmed or suspected invasive pancreatic primary tumor [+1]

Suspected endocrine tumor [+5]

Status: Recruiting

Prognostic Factors in Periampullary Tumors and Cysts

The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Umeå UniversityUpdated: Jan 5, 2022Locations: 1Duration: 10 Years
Eligibility criteria

Recommended surgery for tumor or cyst in the pancreas or periampullary region [+2]

No informed consent (and still alive at study initiation)

Status: Recruiting

Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit

The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.

Participants needed: 1,000
Trial details
Age: 15-90Biological sex: AllType: ObservationalSponsor: Fundacion Miguel ServetUpdated: Sep 21, 2020Locations: 1
Eligibility criteria

All patients operated by the HPB Surgical Unit in the last 10 years (retrospecti... [+1]

Patients not eligible for surgery [+1]